Overview
Melanomas are a type of skin cancer that arises from the pigment-producing cells called melanocytes. They typically appear as dark, irregularly shaped moles or patches on the skin, but can also occur in other parts of the body such as the eyes or mucous membranes. Melanomas are one of the most deadly forms of skin cancer, as they can grow and spread quickly to other parts of the body. Recent research in hematology and oncology has identified several important factors that contribute to the development and progression of melanomas. For example, mutations in certain genes (such as BRAF and NRAS) can activate signaling pathways that promote melanoma growth and survival. Other studies have found that the immune system plays a critical role in controlling melanoma progression, and that manipulating immune cells (such as T cells) can be an effective therapy for some patients. In addition to these basic research findings, there have been exciting advances in clinical treatments for melanomas. These include targeted therapies that selectively attack melanoma cells based on their genetic mutations, as well as immunotherapies that activate the immune system to recognize and destroy melanoma cells. These treatments have significantly improved survival rates for patients with advanced melanomas, and are being further developed and refined in ongoing clinical trials
Research published in this journal
4 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 4 articles above have been cited 8 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2023 · Siberian Journal of Oncology
-
2023 · Siberian journal of oncology
-
2022 · Effective Pharmacotherapy
-
2022 · Journal of Dermatology Research
-
2022 · Journal of Dermatology Research
-
2021 ·
-
2021 · Journal of Dermatology Research
-
2021 · Journal of Dermatology Research
A sample of recent works citing this journal's research on Melanomas, linking to each citing work.